Try our Advanced Search for more refined results
March 19, 2021
Shash et al v. Biogen Inc. et al
Case Number:
1:21-cv-10479
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Kendall Brill & Kelly
- Latham & Watkins
- MoloLamken
- Paul Weiss
- Pomerantz LLP
- Rosen Law Firm PA
- Schubert Jonckheer
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
October 11, 2023
1st Circ. Resurrects Investors' Fraud Claim Against Biogen
The First Circuit on Wednesday revived one claim accusing Biogen Inc. of misleading investors about the effectiveness of its controversial Alzheimer's treatment aducanumab, though it held that the bulk of their securities fraud suit was properly tossed.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login